01 1DISHMAN CARBOGEN AMCIS LIMITED
02 1Edmond Pharma S.R.L.
03 1Edmond Pharma Srl
01 1LEVOBUPIVACAINE
02 1LEVOBUPIVACAINE BASE
03 1Levobupivacaine Hydrochloride
01 2India
02 1Sweden
NDC Package Code : 61876-0728
Start Marketing Date : 2018-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66583-0815
Start Marketing Date : 2023-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66583-0710
Start Marketing Date : 2021-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Levobupivacaine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levobupivacaine, including repackagers and relabelers. The FDA regulates Levobupivacaine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levobupivacaine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levobupivacaine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levobupivacaine supplier is an individual or a company that provides Levobupivacaine active pharmaceutical ingredient (API) or Levobupivacaine finished formulations upon request. The Levobupivacaine suppliers may include Levobupivacaine API manufacturers, exporters, distributors and traders.
click here to find a list of Levobupivacaine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levobupivacaine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levobupivacaine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levobupivacaine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levobupivacaine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levobupivacaine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levobupivacaine suppliers with NDC on PharmaCompass.
We have 3 companies offering Levobupivacaine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
